Quarterly report pursuant to Section 13 or 15(d)

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail)

v3.20.1
Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Schedule Of Cash Flow Supplemental [Line Items]    
Cash paid for interest $ 8,774 $ 9,104
Cash paid for income taxes, net of refunds received 2,110 3,414
Noncash investing and financing activities:    
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment [1] 2,269 (14,660)
Investment in NCM – receipt of common units (see Note 9) 3,620 1,552
Dividends accrued on unvested restricted stock unit awards [2] (256) (108)
NCM    
Noncash investing and financing activities:    
Interest expense - NCM (see Note 9) $ (5,891) $ (4,782)
[1] Additions to theatre properties and equipment included in accounts payable as of March 31, 2020 and December 31, 2019 were $17,260 and $14,991, respectively.
[2]

 

(1)

Below is a summary of dividends paid to stockholders and accrued on unvested restricted stock unit awards during the three months ended March 31, 2020 and 2019:  

 

 

 

 

Amount per Share

 

 

 

 

 

Declaration Date

Record Date

Payable Date

 

of Common Stock

 

 

Total

 

2/21/2020

3/6/2020

3/20/2020

 

$

0.36

 

 

$

42,567

 

 

 

 

 

 

 

 

 

 

 

 

2/22/2019

3/8/2019

3/22/2019

 

$

0.34

 

 

$

39,905